Nishii, K., Ohashi, K., Watanabe, H., Makimoto, G., Nakasuka, T., Higo, H., . . . Kiura, K. (2021). Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression. Oncol Lett.
シカゴスタイル引用形Nishii, Kazuya, et al. "Triple Therapy With Osimertinib, Bevacizumab and Cetuximab in EGFR-mutant Lung Cancer With HIF-1α/TGF-α Expression." Oncol Lett 2021.
MLA引用形式Nishii, Kazuya, et al. "Triple Therapy With Osimertinib, Bevacizumab and Cetuximab in EGFR-mutant Lung Cancer With HIF-1α/TGF-α Expression." Oncol Lett 2021.
警告: この引用は必ずしも正確ではありません.